Human allograft acceptance is associated with immune regulation

Journal of Clinical Investigation

Volumn 106, Issue 1, 2000, Pages 145-155

  VanBuskirk, A M ^a,c   Burlingham, W J ^b   Jankowska Gan, E ^b   Chin, T ^b   Kusaka, S ^b   Geissler, F ^b   Pelletier, R P ^a   Orosz, C G ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c Transplantation Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANIMAL CELL; ARTICLE; DELAYED HYPERSENSITIVITY; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOUSE; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 0033932757     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9171     Document Type: Article

References (60)

1. Starzl, T.E., et al. 1993. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 17:1127-1152.
2. Burlingham, W.J., et al. 1995. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation. 59:1147-1155.
3. Zoller, K M., Cho, S.L. Cohen, J.J., and Harrington, J.T. 1980. Cessation of immunosuppressive therapy after successful transplantation: a national survey. Kidney Int 18:110-114.
4. Uehling, D.T., Hussey, J.L., Weinstein, A.B., Wank, R., and Bach, F.H. 1976. Cessation of immunosuppression after renal transplantation. Surgery. 79:278-282.
5. VanBuskirk, A.M., Wakely, M.E., Sirak, J.H., and Orosz, C.G. 1998. Patterns or allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity. Transplantation. 65:1115-1123.
6. Bickerstaff, A., VanBuskirk, A., Wakely, M., and Orosz, C. 2000. Transforming growth factor-beta and interleukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice. Transplantation. 69:1517-1520.
7. Bouma, G.J., van der Meer-Prins, E.M.W., Van Der Woude, F.J., van Rood, J.J., and Claas, F.H.J. 1995. Relevance of pretransplant donor-specific T cell allorepertoire for human kidney graft survival. Transplantation. 59:969-976.
8. Vaessen, L.M.B., et al. 1994. Differencial avidity and cyclosporine sensitivity of committed donor-specific graft-infiltrating cytotoxic T cells and their precursors. Transplantation. 57:1051-1059.
9. Carrodeguas, L., et al., 1999. Trans vivo analysis of human delayed-type hypersensitivity reactivity. Hum. Immunol. 60:640-651.
10. Tosato, G. 1996. Generation of Epstein-Barr Virus (EBV)-immortalized B cell lines. In Current protocols in immunology. Volume 2. J. Coligan, A. Kruisbeek, E. Shevach, and W. Strober, editors. John Wiley & Sons Inc. New York, New York, USA, 7.22.1-7.22.3.
11. DeVito, L.D., Sollinger, H.W., and Burlingham, W.J 1990. Adsorption of cytotoxic anti-HLA antibodies with HLA class I immunosorbant beads. Transplantation. 49:925-931.
12. Burlingham, W.J., et al. 1999. Focal infiltrates in kidney allografts: developing a model for clinical transplant peripheral tolerance. Graft. 2:253-260.
13. Prop, J., Hutchinson, I.V., and Morris, P.J. 1986. Induction and persistence of suppression of contact hypersensitivity against bystander haptens and alloantigens in rats. Cell Immunol. 99:85-94.
14. Sirak, J.H., Orosz, C.G., Roopenian, D.C., Wakely, E., and VanBuskirk, A.M. 1998. Cardiac allograft tolerance. Failure to develop in interleukin-4-deficient mice correlates with unusual allosensitization patterns. Transplantation. 65:1352-1356.
15. Davies, J.D., Leong, L.Y.W., Mellor, A., Cobbold, S.P., and Waldmann, H. 1996. T cell suppression in transplantation tolerance through linked recognition. J. Immunol. 156:3602-3607.
16. Niederkorn, J.Y., Mayhew, E., and He, Y. 1995. Alloantigens introduced into the anterior chamber of the eye induce systemic suppression of delayed hypersensitivity to third-party alloantigens through "linked recognition". Transplantation. 60:348-354.
17. Kusaka, S., et al. 2000. Clonotype analysis of human alloreactive T cells: a novel approach to studying peripheral tolerance in a transplant recipient. J. Immunol. 164:2240-2247.
18. Gould, D.S. and Auchincloss, H.J. 1999. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today. 20:77-82.
19. Groux, H., et al. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-742.
20. Chen, Y., Kuchroo, V.K., Inobe, J.-I., Hafler, D.A., and Werner, H.L. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1237-1240.
21. D'Orazio, T.J., and Niederkorn, J.Y. 1998. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J. Immunol. 160:2089-2098.
22. Marth, T., Strober, W., and Kelsall, B.L. 1996. High dose oral tolerance in ovalbumin TCR-transgenic mice. J. Immunol. 157:2348-2357.
23. Yamamoto, H., Hirayama, M., Genyea, C., and Kaplan, J. 1994. TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes. J. Immunol. 152:3842-3847.
24. Inge, T.H., Hoover, S.K. Susskind, B.M., Barrett, S.K., and Bear, H.D. 1992. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1. Cancer Res. 52:1386-1392.
25. Qin, L., Ding, Y., and Bromberg, J.S. 1996. Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum Gene Ther. 7:1981-1988.
26. Hewitt, C.W., et al. 1997. Rat renal allograft tolerance is associated with local TGF-beta and absence of IL-2r expression within chimeric immunocytic foci. Transplant. Proc. 29:2183-2184.
27. Xu, X.Y., Honjo, K., Devore-Carter, D., and Bucy, R.P. 1997. Immunosuppression by inhibition of cellular adhesion mediated by leukocyte function-associated antigen-1/intercellular adhesion molecule-1 in murine cardiac transplantation. Transplantation. 63:876-885.
28. Gorczynski, R.M., and Wojcik, D. 1994. A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion. J. Immunol. 152:2011-2019.
29. Takeuchi, T., Lowry, R.P., and Konieczny, B. 1992. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation. 53:1281-1294.
30. Larsen, C.P., et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:434-438.
31. Hall, B.M. 1991. Cells mediating allograft rejection. Transplantation. 51:1141-1151.
32. Perry, L.L., and Williams, I.R. 1995. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specifity of anti-Ia immunotherapy in murine skin allograft recipients. J. Immunol. 134:2935-2941.
33. Loveland, B.E., and McKenzie, I.F.C. 1982. Delayed-type hypersensitivity and allograft rejection in the mouse: correlation of effector cell phenotype. Immunology. 46:313-320
34. Sirak, J., Orosz, C.G., Wakely, E., and VanBuskirk, A.M. 1997. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection. Transplantation. 63:1300-1307.
35. Hutchinson, I.V., Barber, W.H., and Morris, P.J. 1985. Specific suppression of allograft rejection by trinitrophenyl (TNP)-induced suppressor cells in recipients treated with TNP-haptenated donor alloantigens. J. Exp. Med. 162:1409-1420.
36. Qin, S., et al. 1993. "Infectious" transplantation tolerance. Science. 259:974-976.
37. Cobbold, S.P., Adams, E., Marshall, S.E., Davies, J.D., and Waldmann, H. 1996. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol. Rev. 149:5-33.
38. Onodera, K., et al. 1996. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J. Immunol. 157:1944-1950.
39. Niederkorn, J.Y., and Streilein, J.W. 1983. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J. Immunol. 131:2670-2674.
40. Streilein, J.W., Takeuchi, M., and Taylor, A.W. 1997. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Hum. Immunol. 52:138-143.
41. Hutchinson, I.V., and Morris, P.J. 1986. The role of major and minor histocompatibility antigens in active enhancement of rat kidney allograft survival by blood transfusion. Transplantation. 41:166-170.
42. Valujskikh, A., et al. 1998. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J. Clin. Invest. 101:1398-1407.
43. Verbanac, K.M., Carver, F.M., Haisch, C.E., and Thomas, J.M. 1994. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance. Transplantation. 57:893-900.
44. Josien, R., et al. 1998. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J. Clin. Invest. 102:1920-1926.
45. Taga, K., and Giovanna, T. 1992. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148:1143-1148.
46. Qian, S., et al. 1994. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 19:916-924.
47. Starzl, T.E., Murase, N., Thomson, A., and Demetris, A.J. 1996. Liver transplants contribute to their own success. Nat Med. 2:163-165.
48. Everson, G.T., et al. 1999. Early steroid withdrawal in liver transplantation is safe and beneficial. Liver Transpl. Surg. 5(Suppl. 1):S48-S57.
49. Fung, J.J. 1999. Toward tolerance: lessons learned from liver transplantation. Liver Transpl. Surg. 5(Suppl. 1):S90-S97.
50. Qian, S., et al. 1997. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J. Immunol. 158:4654-4661.
51. Dahmen, U., et al. 1994. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation. 58:1-8.
52. Olver, S., Goto, S., Chiba, S., Clouston, A., and Kelso, A. 1998. Persistence of donor-reactive CD4+ T cells in liver and spleen of rats tolerant to a liver allograft. Transplantation. 66:132-135.
53. Burlingham, W.J., et al. 2000. Tumor necrosis factor-alpha and tumor growth factor-betal genotype: partial association with intragraft gene expression in two cases of long-term peripheral tolerance to a kidney transplant. Transplantation. 69:1527-1530.
54. Tran, H.M., et al. 1997. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J. Immunol. 159:2232-2239.
55. Gudmundsdottir, H., and Turka, L.A. 1999. T cell costimulatory blockade: new therapies for transplant rejection. J. Am. Soc. Nephrol. 10:1356-1365.
56. Li, X.C., et al. 1999. Induction of allograft tolerance in the absence of Fas-mediated apoptosis. J. Immunol. 163:2500-2507.
57. Asiedu, C., et al. 1999. Immunoregulatory role of CD8alpha in the veto effect. Transplantation. 67:372-380.
58. Kabelitz, D. 1998. Apoptosis, graft rejection, and transplantation tolerance. Transplantation. 65:869-875.
59. Jacobs, M.J.M., VanDenHoek, A.E.M., VanDePutte, L.B.A., and VanDenBerg, W.B. 1994. Anergy of antigen-specific T lymphocytes is a potent mechanism of intravenously induced tolerance. Immunology. 82:294-300.
60. Malvey, E.-N., Jenkins, M.K., and Mueller, D.L. 1998. Peripheral immune tolerance blocks clonal expansion but fails to prevent the differentiation of Th1 cells. J. Immunol. 161:2168-2177.